Stocks capped a choppy day of trading on Wall Street with more losses Thursday after an early Big Tech rally faded and a ...

Asian shares are lower after choppy trading on Wall Street that saw more losses as investors assess President Donald Trump's ...

Q2 2025 Management View CEO Christopher S. Boerner highlighted, "Our growth portfolio delivered another strong quarter with sales increasing 17% year-over-year, primarily driven by demand across all ...

Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 ...

Cobenfy is one of the key products Bristol is counting on to take up the slack as patents on three of its top-selling drugs ...

Bristol-Myers Squibb Company (BMY) reported second-quarter 2025 adjusted earnings per share (EPS) of $1.46, which comfortably ...

Bristol Myers Squibb posted much better-than-expected second-quarter results on Thursday on strong sales of its best-selling ...

Bristol Myers Squibb had a strong quarter, with key drugs old and new coming in either above or in line with Wall Street’s ...

Bristol-Myers Squibb (BMY) shares rise after beating Q2 forecasts, raising 2025 revenue outlook, and showcasing growth in key ...

PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Bristol Myers Squibb Co. (BMY) on Thursday reported second-quarter profit of $1.31 billion. On a per-share basis, the Princeton, New Jersey-based company ...

Bristol Myers Squibb and Pfizer are launching a direct-to-patient program with 40% discount on Eliquis, reducing the monthly cost from $606 to $346 for eligible patients.